News

The DHVI is committed to fostering an environment of inclusion in which highly qualified faculty, staff, and students from diverse talent pools experience a genuine sense of belonging, engagement, and achievement. Thank you Judy Seidenstein, Chief Diversity Officer, Duke School of Medicine, for this special presentation allowing us to engage in topics of self awareness and inclusion.

The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Duke Human Vaccine Institute - IVQAC Laboratory, Durham, North Carolina based on results of a recent January 2018 on-site inspection as part of the CAP's Accreditation Programs.

Dr. Barton Ford Haynes is Professor of Medicine, Research Professor of Global Health, and Professor of Immunology at the Duke Human Vaccine Institute at the Duke University School of Medicine. Dr. Haynes also serves as Director of the Human Vaccine Institute in the Department of Medicine.

The increasing threat of infectious diseases is intensifying the need for breakthrough technologies and capabilities to protect first responders and equip them with therapeutics that can halt the impact of infectious agents.

The Duke Human Vaccine Institute received a $5,362,962 (includes the base period and all options), seven-year (if all term options are exercised) contract from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to perform viral load assays for laboratories involved in HIV/AIDS research.

Duke researchers make up one percent of the top one percent of researchers in their respective fields, according to a report released by Clarivate Analytics.

The Duke Human Vaccine Institute has received a $12.8 million, 30-month grant from the U.S. Department of Defense, Defense Advanced Research Projects Agency (DARPA) to develop a system capable of halting viral pandemics within 60 days.

The Duke Human Vaccine Institute received a renewal of a $41,463,666 (includes the base period and all options), seven-year (if all term options are exercised) contract from the National Institute of Allergy and Infectious Diseases to house quality assurance programs for laboratories involved in HIV/AIDS research.

A research team led by Duke University scientists on Friday announced that it found clues in immune systems that could help develop an effective HIV vaccine.

Duke Health is one of eight sites nationally selected to participate in a program to help train first responders and other workers in properly handling infectious disease emergencies.